Investors / UN I+D+I Tech Transfer
UN I+D+I Tech Transfer
Venture capital
UN I+D+I Tech Transfer is a private capital fund that invests in and supports early-stage innovative projects, mainly generated within the University of Navarra and its research centres. It was created through a collaboration between the venture capital manager Clave and Innovation Factory, a University of Navarra project.
Invests inHealthcare & BiotechFood & Agriculture
In its own wordsuniversity spinoutstech transferearly stageinnovation
Your fit with UN I+D+I Tech Transfer
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsUN I+D+I Tech Transfer lists 11 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (62%), Food & Agriculture (15%) and Media & Entertainment (8%). 100% of its companies are based in Spain. It invests most often alongside Sodena, AMR Action Fund and Clave.
No funding round on record names UN I+D+I Tech Transfer yet, so the figures come from its portfolio page.
Round figures show recent activity, not UN I+D+I Tech Transfer's whole history. Rounds on record name 0 companies; its own site lists 11. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 27th | 11 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 89th | 62% in its largest sector |
| Reach | 19th | 1 country |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers11100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 62% | 15% |
| Food & Agriculture | 15% | 3% |
| Media & Entertainment | 8% | 4% |
| Space & Defense | 8% | 3% |
| AI & Machine Learning | 8% | 18% |
Co-investor network
who it backs companies with, and who they back togetherCompare UN I+D+I Tech Transfer head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
11 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Abanza develops and provides soft tissue fixation solutions for orthopedic and arthroscopic procedures. | Healthcare & Biotech | Portfolio page | ||
| The company designs, develops, manufactures, and commercializes solutions for human breath analysis. | Healthcare & Biotech | Portfolio page | ||
| Genbioma develops clinically validated postbiotic solutions that support metabolic balance and enable differentiated health products. | Healthcare & Biotech | Portfolio page | ||
| Medicalplasmas develops and applies cold plasma technology for medical use, particularly for treating chronic wounds. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| MOA Foodtech produces next-generation functional ingredients from agrifood byproducts using AI-driven biotechnology | Food & AgricultureAI & Machine Learning | Portfolio page | ||
| Nucaps develops and produces functional ingredients, including protein microencapsulated bioactives and probiotics, for use in food, supplements, and other products | Food & AgricultureHealthcare & Biotech | Portfolio page | ||
| Polimerbio designs and develops biodegradable polymer-based medical devices and sanitary products | Healthcare & Biotech | Portfolio page | ||
| Predictheon accurately predicts adverse events, yielding improved health outcomes, savings and value for all stakeholders. | Healthcare & Biotech | Portfolio page | ||
| Telum Therapeutics is a global drug discovery biotechnology company specializing in the use of Engineered Phage Lytic Proteins as new antimicrobial products. | Healthcare & Biotech | Portfolio page | ||
| Tweet Binder provides Twitter hashtag analytics, allowing users to create impact reports on hashtags or keywords and track their campaigns and events. | Media & EntertainmentSpace & Defense | Portfolio page |
About this data
site last read 7 Nov 2026- Site
- uniditechtransfer.com
- Last read
- 7 Nov 2026
- Watching since
- 7 Nov 2026
- Companies checked
- 11
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get UN I+D+I Tech Transfer's profile as data
Pull UN I+D+I Tech Transfer's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/uniditechtransfer.com
# also
GET /v1/firms/uniditechtransfer.com/portfolio
GET /v1/firms/uniditechtransfer.com/coinvestors
GET /v1/firms/uniditechtransfer.com/news